Effect of Arctium lappa L. in the dextran sulfate sodium colitis mouse model

World Journal of Gastroenterology

Volumn 16, Issue 33, 2010, Pages 4193-4199

  Huang, Tzou Chi ^a   Tsai, Shinn Shyong ^a   Liu, Li Fang ^a   Liu, Yu Lin ^a   Liu, Hung Jen ^a,b   Chuang, Kuo Pin ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Arctium lappa L.; Colitis; Cytokine; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ARCTIUM LAPPA EXTRACT; DEXTRAN SULFATE; INTERLEUKIN 6; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCTIUM; ARCTIUM LAPPA; ARTICLE; BODY WEIGHT; CELL INFILTRATION; COLON INJURY; COLON ULCER; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; EROSION; HEMATOCHEZIA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MOUSE; NONHUMAN; ULCERATIVE COLITIS; WEIGHT REDUCTION;

EID: 77956588473     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i33.4193     Document Type: Article

References (22)

1. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594
2. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541-546
3. Kato Y, Watanabe T. Isolation and characterization of a xyloglucan from gobo (Arctium lappa L.). Biosci Biotechnol Biochem 1993; 57: 1591-1592
4. Holetz FB, Pessini GL, Sanches NR, Cortez DA, Nakamura CV, Filho BP. Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz 2002; 97: 1027-1031
5. Lin CC, Lu JM, Yang JJ, Chuang SC, Ujiie T. Anti-inflammatory and radical scavenge effects of Arctium lappa. Am J Chin Med 1996; 24: 127-137
6. Dos Santos AC, Baggio CH, Freitas CS, Lepieszynski J, Mayer B, Twardowschy A, Missau FC, dos Santos EP, Pizzolatti MG, Marques MC. Gastroprotective activity of the chloroform extract of the roots from Arctium lappa L. J Pharm Pharmacol 2008; 60: 795-801
7. Knipping K, van Esch EC, Wijering SC, van der Heide S, Dubois AE, Garssen J. In vitro and in vivo anti-allergic effects of Arctium lappa L. Exp Biol Med (Maywood) 2008; 233: 1469-1477
8. Tremaine WJ. Refractory IBD: medical management. Neth J Med 1997; 50: S12-S14
9. Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol 2008; 6: 1112-1116
10. Kim CJ, Kovacs-Nolan JA, Yang C, Archbold T, Fan MZ, Mine Y. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem 2010; 21: 468-475
11. Kwon KH, Murakami A, Hayashi R, Ohigashi H. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem Biophys Res Commun 2005; 337: 647-654
12. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434
13. Ni J, Chen SF, Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1996; 39: 234-241
14. Joo YE, Karrasch T, Mühlbauer M, Allard B, Narula A, Herfarth HH, Jobin C. Tomato lycopene extract prevents lipopolysaccharide- induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One 2009; 4: e4562
15. Kurita-Ochiai T, Fukushima K, Ochiai K. Volatile fatty acids, metabolic by-products of periodontopathic bacteria, inhibit lymphocyte proliferation and cytokine production. J Dent Res 1995; 74: 1367-1373
16. Kvale D, Brandtzaeg P. Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 1995; 36: 737-742
17. LeLeiko NS, Walsh MJ. The role of glutamine, short-chain fatty acids, and nucleotides in intestinal adaptation to gastrointestinal disease. Pediatr Clin North Am 1996; 43: 451-470
18. Kleessen B, Blaut M. Modulation of gut mucosal biofilms. Br J Nutr 2005; 93 Suppl 1: S35-S40
19. Videla S, Vilaseca J, Antolín M, García-Lafuente A, Guarner F, Crespo E, Casalots J, Salas A, Malagelada JR. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 2001; 96: 1486-1493
20. Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 2006; 6: 31
21. Krakauer T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol 2002; 24: 113-119
22. Shan J, Fu J, Zhao Z, Kong X, Huang H, Luo L, Yin Z. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation. Int Immunopharmacol 2009; 9: 1042-1048